Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$MJTV is looking good! found some balance and the spread is tightening. Small float, this is going to run up hard sooner or later! looking forward to it with all the great guys here on the board!
Share structure on this is so tight that any good news and it will run like a beast.
Acne is a big market that any small piece means big revenues. My concerns about this company being crushed by the big players are not as big as my hopes for that piece and/or acquisition.
that's a lot of followers for a brand new ticker. Gaining traction fast, like it
yeah, wonder if they will get into the MJ sector though give the ticker name... I like the thought
clarification... wondering whether there will be MJ sector products. That could be a huge addition.
So ticker change into MJ sector. Any one know what products are going to be sold and when?
This stock has scary potential. Increasing volume, opportunity to gap (according to L2), big news over the last couple weeks, and taking big steps forward.
new ticker leads me to believe they are going into an industry that will be hot again this spring. The run last year was crazzzzyyyyyy.
agreed. solid increases in volume, solid news, super tight share structure. All it needs is a little more visibility to take off.
really like the increasing volume here. Expectations are big with a float this tight.
Since the low of .09, this has been a huge gainer with volume increases.
CO is good to go now
http://ir.stockpr.com/pazoo/press-releases/detail/1531
BMAK does retail too. Notice they are also on the bid just below their ask.
Ever contemplate that they may be trying to scare the ask down to their bid to help out a buyer through them?
Look at the volume today... it's incredibly low... Clearly no dilution.
Also contemplate what those shares may have been for- maybe direct investments into the company instead of convertible debt financing?
what you may have noticed is after the sell-off this morning the stock bounced back and is very healthy.... The volume is still light, but that's the case all across the OTC right now for the most part.
There is still a huge gap between bid and ask which gives me some good feelings about ending the day positive.
Anyone that doesn't have L2 was even more surprised by that open...
Someone with a couple million (about 3 to be exact) literally sold directly into the bid. I'm not one for conspiracy theories, but given that there were no debt conversions coming due, this looks like someone trying (unsuccessfully) to tank the share price.
Bid support is there now at 0045 and 0046. There will be a lot of people laughing at those selling at these prices within a couple months.
anyone new to the board should review the intro and sticky's in addition to carefully reviewing the financials to see the full picture.
I had a conflicting meeting so I will have to catch the non-taped version.
It just happened.
(www.cannawebcast.com) on Thursday, September 10, 2015 at 11:00 AM EDT.
I've been watching L2 closely.
There's been some selling into the bid. There isn't any rational reason for it other than that the stock ran from .003 to .008 and some pullback is to be expected.
The sellers may be some people who wanted a really quick flip, then when they found out via the CEO yesterday that the CO lab will be getting their license to test and report revenue in mid Oct, decided to get out for now.
Good luck to all who are selling now..... I hope you put it into something that gives you 100-200% returns, because that's what you are walking away from here.
CF,
I disagree with you. This product can be used in commercial applications in grow operations as well as any large commercial building. Yes, it's a nice relationship/business development tool, but the revenues could be substantial.
I'm going to go out on a limb and make the assumption that any revenue will be 1 time payments based on system sale/installments, with a % of that total sale. If they make a $500,000 sale, I would guess they will get $100,000 (20%) or so.
The water conservation product could be enormous, but here's the important question.... What are Pzoo's commissions on any systems sold and how much of that goes to the sales team?
Being aligned with all of these revenue producing products is awesome, but we need EBITA (Earnings Before Interest, Taxes, Amortization). Once again, we see a PR that has almost no impact on the stock price. I'm fairly convinced that we won't see a substantial change in price until we hear something more finite about CO revenues or and update on convertible debt payoffs.
Top 4 reasons Pazoo is worth investing in
1) Steep Hill methodology and first right of refusal
They have been studying the plant and perfecting their testing methodology for 8+ years.
2) Strategic positioning
Pazoo has lab locations in the three most profitable states for testing (Nevada, Oregon, and Colorado- in that order). Testing will begin in all three by the 4th quarter (we could still have CO in the 3rd)
3) CannabisKing Distribution
Management has been proactive and created another revenue stream for the company with products expected to have substantial footholds in the sector (MJ Payments, AccuVape, and several others)
4) Transparency and Diligence of Management
David Cunic (CEO) and the pzoo team have been straightforward and upfront about their progress. There have been setbacks and delays that were out of their control, but they have used that time positively. They moved into the sector late last year and already have partnered with the best in class (Steep hill), have 3 testing labs, other revenue, and future expansion plans.
Competitive Advantage: PZOO's 2 primary competitors are Digipath (Nevada) and Cannlabs (Colorado).
1) Testing Methodology- The closest competitors have only been testing for 2-3 years and this has been evident in a various instances including the independent Nevada tests scoring Steep hill at 241/250 and the closest competitor around 190. CannLabs also recently could not perform tests promised to their customers due to lack of expertise.
2) Scope
Each of those competitors only have 1 lab, in 1 state, and have made 0 announcements about expansion. Pzoo will have 3 this year and has announced plans to open 2 more labs in 2016.
3) Effectiveness and Efficiency
Digipath had their first PR saying they were testing MJ in early June and claimed to be supplying the first open dispensary in Vegas. The reality is that they are only testing a couple samples a week and running their lab at a loss, bleeding cash. For all of you who want to be able to say we have "testing revenue coming in" this is our current alternative. Until substantial grow operations have produced crops, there is no point to having the facility open and running at a loss.
Potential Concerns:
1) Financing
Until Pzoo has steady revenue and is running at a profit (projected by end of Q4, but likely beginning of Q1 in 2016), having access to operating capital without taking out toxic debt will be imperative. The PR discussing Luchesi bringing them into contact with private financing is encouraging. Hopefully we will find out whether they were successful soon.
2) Federal Regulation
Like any company in the MJ sector, Federal regulation could severely hamper or halt PZOOs progress. There are no presidential candidates that have a legitimate chance of winning who have spoken out against the MJ industry at this point.
FIRST AND FOREMOST:
The topic of this board should be pzoo. Not anyone on this board unless you're responding to a post.
Let's talk about the webcast and put it into perspective. I agree that there's absolutely no proof that it will substantially push the pps up. What I do know is that volume has been fairly light <10m shares/day on the 10 day avg and pps has doubled in the last couple weeks.
The goal of this webcast is to bring more eyes to pzoo. Undoubtedly it will bring a few more buyers and a number of people to the FB page, but I don't expect to see anything big until we start getting substantial revenue PRs.
This is just another step in the right direction for a company that is building a lot of momentum going into the fall.
the topic on this board should be pzoo, their business and those affiliated with their business. Let's keep it there.
ok ok...
The goal isn't to throw anyone entirely under the bus and run them over here. The point has been made and let's point our attention to pzoo.... Nothing else is worth talking about on this board.
Your first clue that people tend to dislike AB is the line below all of his posts.
I like light to be shed upon everything and everyone. Anyone looking at the financials can see that there has been a huge amount of convertible debt issued to get the company up and running. Setting up labs, buying equipment JUST THE STEEP HILL license was 2 million dollars. Acquiring the remainder of the labs in CO and NV was expensive as well.... As pzoo moves to more traditional financing, this toxic debt will be removed from the books and investors like myself will be able to breathe easier.
cmon man just give it up. You would do your investors more good by just swallowing your pride, saying you were wrong, and moving forward than by obstinately claiming "they will fail because I say so!!!!!!!!"
Best post of the day... hands down
How many ways can you manage to look foolish in 1 day?
As a self-promoted "expert" in the field, how do you not know that it is ILLEGAL to be testing in Nevada. The question being answered was, "What steps remain before Las Vegas begins testing?" You're faulting the company for picking up an additional piece of equipment to expand testing capacity? really? You want them to calibrate equipment before the lab is doing testing on a regular basis?
Oh and regarding your earlier incorrect comment about cannabis king sales... Let's say the avg is $450/account for the 200 accounts expected to be signed by the end of Q1 (you gave it the top end, I'd rather be realistic and put it in the middle). That is $450 x 200 accounts PER MONTH. Rough projections put that at $90,000/month and 1,080,000 per year.
Keep coming up with more reasons and excuses to tell your dwindling number of followers not to buy pzoo
Noooooo kidding man. Any company would want their debt converting at a higher rate (should any actually convert). I disagree with the desperation though. I think we've seen an uptick in volume as well as in share price due to the huge strides that pzoo has made over the last month or so and summer is coming to an end. That said... the conversions aren't for a couple months, so the pps at the end of august is a bit irrelevant.
It's been stated multiple times by Cunic that at least a large portion of the convertible debt maturing this fall (700k, not 1mm as you indicated) will be pre-paid.
Everyone is in agreement that the Q3 financials are going to be in the red given that it's 2/3 through the quarter and the only lab that could potentially be testing is CO.
What are you basing the "most likely operating loss" for CannabisKing on? The conference call was very clear on this matter. NO additional staff had been hired other than on commission only basis. How could they run at an operating loss at that point?
Go to twitter with baseless claims. It's easier to pick up uneducated followers there.
sounds good and so do the rest of us......
The fundamentals are there, it's just a matter of when the company reveals that to the market and when they can their lab doors open.
welcome to the dysfunctional family lol...
The Las Vegas lab is 100% functional/operational. It is not currently legal to test in Las Vegas without the final pesticide requirements and Pzoo will begin testing as soon as possible.
I think now would be a great time to step back and take a look at pzoo share price historically as well as make some inferences about what may happen shortly...
If you look at the chart over the last year, pzoo has spiked to over 4cents twice, and over 2c one other time.
Let's compare the similarities. The surge to over 2c this spring and early summer had everything to do with the NV facility opening. The pps drop-off has been due to no the NV lab not being able (legally allowed) to produce revenue, delays with the CO facility, and the delays for the financials.
We are on the doorstep of getting CO going and revenues coming in. Nevada and Oregon will be revenue producing some time this fall. CannabisKing wasn't even part of the equation at that point and figures to be a pretty big deal given how much Cunic and others are talking about it.
The other and probably even more immediate item on the PR today was that this consulting firm is helping bring them financing without going to convertible debt.
These are the keys to moving from having amazing potential to business success. The only reason the pps is even in this ballpark is because pzoo is still in that "has potential" phase. Being able to buy shares in the subs really is a gift and I agree with dolphin's earlier post. On a day where the overall market is down, where we have basically doubled up in the last week and a half, to hold our pps is a huge sign of strength. With regards to the potential PPS by years end, I'm a little more conservative. I think we will be sitting in the 3-5c range at minimum by the end of the year DEPENDING on how soon all 3 labs are testing and how big the sales from Cannabisking really are.
I won't tell anyone to buy or sell their stock and as always, this post is all my opinion, but I'd recommend you at least consider buying. No one likes chasing a stock from behind.
Yeah I'm with you on that one, but also understanding where the company is standing as well as what information they have released recently.
They had a conference call, but have yet to release any revenue information regarding sales from CannabisKing or labs beginning testing. The latter is when I really expect volume to get going and pps to very substantially increase (.02+)
These are reasonable projections given the assumptions stated. I'd also add a couple though.
1) The MJ sector has traditionally broken out and up in the spring. This tends to slingshot any stock in the MJ sector with good momentum. With 3 open labs, Cannabis King and financials coming out in february, the timing is just about perfect for a big pps jump.
2) I believe the 2.5 million Peter was referring to (below) is an annual revenue number, not quarterly and is absolutely reasonable for 2016. 5million could also be in reach depending on how early in 2015 the 4th and 5th labs are testing in the year or if recreational pot passes on the ballot in Nevada.
Cut and pasted for ease of reading:
Feel free to correct me if I'm wrong on my calculations. The Price/Sales ratio of our competitor, CannLabs, is about 29. Now, considering PZOO's outstanding share count is 728 million, we can get a rough estimate. If PZOO brings in a measly 2.5 million after they have 4 different streams of revenue (low expectations), the pps would be around .10. Thus, 5 million would give you a share price of .20. All very realistic estimates for the first quarter or two...if not more. You would see even a higher share price if momentum got on their side or they announced expansion into other states! Once revenue starts, things should begin looking real good!!!
yes... that was actually directly addressed on the conference all earlier this week by CEO Cunic. There is only one dispensary open and there is very little demand for testing currently (without pesticide requirements). Based on the number of tests being run, digipath is earning revenue, but running their lab at a loss. Cunic is unwilling to start testing in the lab until it is running at a profitable level.
Another company beginning to test doesn't indicate their equipment is of a specific quality level. The claim you were referring to was independent researchers who reported that PZOO scored 241/250 and no other lab in the state scored over 190.
This is fantastic post and a definite read for anyone deciding whether to buy.
analysis+ link
Sorry for the double post, just wanted everything in one place.
https://www.tradingview.com/x/qDxjfXbz/
Hey folks! I got to charting and noticed something you might like to see. This is a stock most of us have had a bit of experience with and you may feel one way or the other about it generally, but take a look at this and make your own assessment. In my opinion, get your sneakers on cuz we’re goin for a little run.
I pulled the chart back to look at the last year and noticed that PZOO's in a downtrend that started over a year ago in May 2014. It’s clear as day looking at the pic on top. Zooming in to the last couple months we can see it confirmed in the purple channel. You really have to try not to see it. There are confirmation points of a downward channel and resistance along it starting at the left-pointing arrow at the top left, ending at the right-pointing arrow at the bottom right and three points in between.
I put two red thumbs up where the confirmation points aren’t touching the top trendline, but you have a parallel trajectory. But, at the downward facing red arrow you have a “hand of God” run right along that trendline. It's almost like they did it on purpose. From there, over the course of a couple weeks, resistance finally turns into support, and then an upward curve that seems pretty hard to misconstrue. That’s a breakout.
If you didn’t have the stones to buy at .0038 I can’t really blame you. There were nay-sayers talking about a fall into the trips, but f that weak sauce. If you bought at .0038 you’d already have just about doubled your money, and it doesn’t look like it's going to slow down. This is a significant pattern break of a year+ long downtrend and it just happens to coincide with a gain in company momentum.
So, you may want to get a piece of this. I see today as being profitable and it could carry through into the fall depending on PR that may come out now that they have their filings in order. As always, if I fucked something up here or if there’s any flaw in my analysis, please don’t hesitate to offer critiques. Make that money suckas!!!
Chart analysis from one of the chart experts in the investor group. It's just his 2 cents, but he's been right at almost every turn before.
Hey folks! I got to charting and noticed something you might like to see. This is a stock most of us have had a bit of experience with and you may feel one way or the other about it generally, but take a look at this and make your own assessment. In my opinion, get your sneakers on cuz we’re goin for a little run.
I pulled the chart back to look at the last year and noticed that PZOO's in a downtrend that started over a year ago in May 2014. It’s clear as day looking at the pic on top. Zooming in to the last couple months we can see it confirmed in the purple channel. You really have to try not to see it. There are confirmation points of a downward channel and resistance along it starting at the left-pointing arrow at the top left, ending at the right-pointing arrow at the bottom right and three points in between.
I put two red thumbs up where the confirmation points aren’t touching the top trendline, but you have a parallel trajectory. But, at the downward facing red arrow you have a “hand of God” run right along that trendline. It's almost like they did it on purpose. From there, over the course of a couple weeks, resistance finally turns into support, and then an upward curve that seems pretty hard to misconstrue. That’s a breakout.
If you didn’t have the stones to buy at .0038 I can’t really blame you. There were nay-sayers talking about a fall into the trips, but f that weak sauce. If you bought at .0038 you’d already have just about doubled your money, and it doesn’t look like it's going to slow down. This is a significant pattern break of a year+ long downtrend and it just happens to coincide with a gain in company momentum.
So, you may want to get a piece of this. I see today as being profitable and it could carry through into the fall depending on PR that may come out now that they have their filings in order. As always, if I messed up something up here or if there’s any flaw in my analysis, please don’t hesitate to offer critiques. Make that money suckas!!!